BACKGROUND: Reactive oxygen species (ROS) are generated by cellular metabolism as well as by exogenous agents. While ROS can promote cellular senescence, they can also act as signaling molecules for processes that do not lead to senescence. Telomere homolog oligonucleotides (T-oligos) induce adaptive DNA damage responses including increased DNA repair capacity and these effects are mediated, at least in part, through p53. OBJECTIVE: Studies were undertaken to determine whether such p53-mediated protective responses include enhanced antioxidant defenses. METHODS: Normal human fibroblasts as well as R2F fibroblasts expressing wild type or dominant negative p53 were treated with an 11-base T-oligo, a complementary control oligo or diluents alone and then examined by western blot analysis, immunofluorescence microscopy and various biochemical assays. RESULTS: We now report that T-oligo increases the level of the antioxidant enzymes superoxide dismutase 1 and 2 and protects cells from oxidative damage; and that telomere-based gammaH2AX (DNA damage) foci that form in response to T-oligos contain phosphorylated ATM and Chk2, proteins known to activate p53 and to mediate cell cycle arrest in response to oxidative stress. Further, T-oligo increases cellular ROS levels via a p53-dependent pathway, and these increases are abrogated by the NAD(P)H oxidase inhibitor diphenyliodonium chloride. CONCLUSION: These results suggest the existence of innate telomere-based protective responses that act to reduce oxidative damage to cells. T-oligo treatment induces the same responses and offers a new model for studying intracellular ROS signaling and the relationships between DNA damage, ROS, oxidative stress, and cellular defense mechanisms.
BACKGROUND:Reactive oxygen species (ROS) are generated by cellular metabolism as well as by exogenous agents. While ROS can promote cellular senescence, they can also act as signaling molecules for processes that do not lead to senescence. Telomere homolog oligonucleotides (T-oligos) induce adaptive DNA damage responses including increased DNA repair capacity and these effects are mediated, at least in part, through p53. OBJECTIVE: Studies were undertaken to determine whether such p53-mediated protective responses include enhanced antioxidant defenses. METHODS: Normal human fibroblasts as well as R2F fibroblasts expressing wild type or dominant negative p53 were treated with an 11-base T-oligo, a complementary control oligo or diluents alone and then examined by western blot analysis, immunofluorescence microscopy and various biochemical assays. RESULTS: We now report that T-oligo increases the level of the antioxidant enzymes superoxide dismutase 1 and 2 and protects cells from oxidative damage; and that telomere-based gammaH2AX (DNA damage) foci that form in response to T-oligos contain phosphorylated ATM and Chk2, proteins known to activate p53 and to mediate cell cycle arrest in response to oxidative stress. Further, T-oligo increases cellular ROS levels via a p53-dependent pathway, and these increases are abrogated by the NAD(P)H oxidase inhibitor diphenyliodonium chloride. CONCLUSION: These results suggest the existence of innate telomere-based protective responses that act to reduce oxidative damage to cells. T-oligo treatment induces the same responses and offers a new model for studying intracellular ROS signaling and the relationships between DNA damage, ROS, oxidative stress, and cellular defense mechanisms.
Authors: William A Pryor; Kendall N Houk; Christopher S Foote; Jon M Fukuto; Louis J Ignarro; Giuseppe L Squadrito; Kelvin J A Davies Journal: Am J Physiol Regul Integr Comp Physiol Date: 2006-04-20 Impact factor: 3.619
Authors: M D Gray; J C Shen; A S Kamath-Loeb; A Blank; B L Sopher; G M Martin; J Oshima; L A Loeb Journal: Nat Genet Date: 1997-09 Impact factor: 38.330
Authors: Luke Wojdyla; Neelu Puri; Amanda L Stone; Nan Sethakorn; Srijayaprakash B Uppada; Joseph T Devito; Marc Bissonnette Journal: Biochem Biophys Res Commun Date: 2014-03-12 Impact factor: 3.575
Authors: Erik R Westin; Nukhet Aykin-Burns; Erin M Buckingham; Douglas R Spitz; Frederick D Goldman; Aloysius J Klingelhutz Journal: Antioxid Redox Signal Date: 2011-01-17 Impact factor: 8.401
Authors: Neelu Puri; Ryan T Pitman; Richard E Mulnix; Terrianne Erickson; Audra N Iness; Connie Vitali; Yutong Zhao; Ravi Salgia Journal: Cancer Lett Date: 2013-09-14 Impact factor: 8.679
Authors: Angela N Sheerin; S Kaye Smith; Katrin Jennert-Burston; Amy J Brook; Marcus C Allen; Badr Ibrahim; Dawn Jones; Corrin Wallis; Katrin Engelmann; William Rhys-Williams; Richard G A Faragher; David Kipling Journal: Aging Cell Date: 2011-12-29 Impact factor: 9.304
Authors: Jossimara Polettini; Faranak Behnia; Brandie D Taylor; George R Saade; Robert N Taylor; Ramkumar Menon Journal: PLoS One Date: 2015-09-23 Impact factor: 3.240
Authors: Elizabeth Córdoba-Lanús; Sara Cazorla-Rivero; Adriana Espinoza-Jiménez; Juan P de-Torres; María J Pajares; Armando Aguirre-Jaime; Bartolomé Celli; Ciro Casanova Journal: Respir Res Date: 2017-04-13